Rockville’s Emmes Acquires UK-Based Orphan Reach

Published on :

ROCKVILLE, Md., May 12, 2021 /PRNewswire/ — Emmes (the “Company”), a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation and a portfolio company of Behrman Capital, today announced that it has acquired Orphan Reach, a CRO specialized in clinical research related to rare diseases. Financial terms of the transaction were not disclosed.

Top Life Science Employers in Maryland, 2020

Published on :

The combination of a booming biotech market with an additional surge of hiring by vaccine and diagnostic companies in Maryland has resulted in record-low unemployment and competition for talent at an all-time high.

These Philosophies Have Propelled The Emmes Corporation to Become a Leading International Clinical Research Organization

Published on :

These Philosophies Have Propelled The Emmes Corporation to Become a Leading International Clinical Research Organization Emmes Shows That Doing Good is Good for Science, Medicine and Business     The [….]